je.st
news
Costly hepatitis drug Sovaldi rattles industry
2014-03-02 05:54:49| Biotech - Topix.net
When the Food and Drug Administration approved a medication called Sovaldi in December, it was hailed as a breakthrough in the fight against hepatitis C, a blood-borne disease that affects 3.2 million Americans and kills more people in the U.S. annually than AIDS.
Tags: industry
drug
costly
hepatitis
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||